Pioglitazone Reduces Neointima Formation After Coronary Stent Implantation - Pioglitazone Reduces Neointima Formation After Coronary Stent Implantation

Description:

The goal of the study was to evaluate the effect on neointima formation of treatment with pioglitazone, an oral antidiabetic drug, compared with placebo in nondiabetic patients undergoing coronary stent implantation for de novo lesions.